Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
- PMID: 25933208
- DOI: 10.1097/CMR.0000000000000164
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Abstract
Understanding differences in survival across distinct subgroups of melanoma patients may help with the choice of types of therapy. Tumor-infiltrating lymphocytes (TILs) are considered a manifestation of the host immune response to tumor, but the role of TILs in melanoma mortality is controversial. The aim of this study was to investigate independent prognostic factors for melanoma mortality. We carried out a 10-year cohort study on 4133 melanoma patients from the same geographic area (Lazio) with primary cutaneous melanoma diagnosed between January 1998 and December 2008. The probability of survival was estimated using Kaplan-Meier methods and prognostic factors were evaluated by multivariate analysis (Cox proportional hazards model). The 10-year survival rate for melanoma decreased with increasing Breslow thickness (Pfor trend<0.0001) and with age (Pfor trend<0.0001) whereas survival increased with increasing levels of TILs (Pfor trend=0.0001). The 10-year survival rate for melanoma divided into TILs intensity as scanty, moderate, and marked was 88.0, 92.2, and 97.0%, respectively. In the multivariate Cox model, the presence of high levels of TILs in primary invasive melanomas was associated with a lower risk of melanoma death (hazard ratio 0.32; 95% confidence interval 0.13-0.82) after controlling for sex, age, Breslow thickness, histological type, mitotic rate, and ulceration. After including lymph node status in the multivariate analysis, the protective effect of marked TILs on melanoma mortality remained (hazard ratio 0.37; 95% confidence interval 0.15-0.94). The results of this study suggest that the immune microenvironment affects melanoma survival.
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.J Clin Oncol. 2007 Mar 1;25(7):869-75. doi: 10.1200/JCO.2006.08.9755. J Clin Oncol. 2007. PMID: 17327608
-
Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.J Clin Oncol. 2012 Jul 20;30(21):2678-83. doi: 10.1200/JCO.2011.37.8539. Epub 2012 Jun 18. J Clin Oncol. 2012. PMID: 22711850
-
High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.Arch Dermatol Res. 2021 Jan;313(1):57-61. doi: 10.1007/s00403-020-02067-0. Epub 2020 Apr 8. Arch Dermatol Res. 2021. PMID: 32266533
-
[Problems in defining melanoma regression and prognostic implication].Actas Dermosifiliogr. 2009 Nov;100(9):759-66. Actas Dermosifiliogr. 2009. PMID: 19889297 Review. Spanish.
-
The changing prognosis of melanoma.Curr Oncol Rep. 2000 Jul;2(4):322-8. doi: 10.1007/s11912-000-0025-9. Curr Oncol Rep. 2000. PMID: 11122860 Review.
Cited by
-
Acral Melanoma Is Infiltrated with cDC1s and Functional Exhausted CD8 T Cells Similar to the Cutaneous Melanoma of Sun-Exposed Skin.Int J Mol Sci. 2023 Mar 1;24(5):4786. doi: 10.3390/ijms24054786. Int J Mol Sci. 2023. PMID: 36902214 Free PMC article.
-
Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma.Oncotarget. 2016 Dec 6;7(49):81830-81838. doi: 10.18632/oncotarget.13244. Oncotarget. 2016. PMID: 27833084 Free PMC article. Review.
-
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma.Biomedicines. 2021 Dec 16;9(12):1930. doi: 10.3390/biomedicines9121930. Biomedicines. 2021. PMID: 34944746 Free PMC article.
-
Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.J Natl Cancer Inst. 2020 Sep 1;112(9):875-885. doi: 10.1093/jnci/djaa012. J Natl Cancer Inst. 2020. PMID: 32061122 Free PMC article. Review.
-
Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma.Oncotarget. 2017 Feb 28;8(9):14759-14769. doi: 10.18632/oncotarget.14736. Oncotarget. 2017. PMID: 28107203 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical